Form 4: Bioventus Director Sells 10,000 Shares

Bioventus Inc. Director Guy P. Nohra sold 10,000 shares of Class A Common Stock under a Rule 10b5-1 plan.

Summary

• Guy P. Nohra, a Director of Bioventus Inc. (BVS), reported the sale of 10,000 shares of Class A Common Stock.
• The transaction occurred on December 4, 2025.
• The shares were sold at a weighted average price of $7.5658 per share, with individual transactions ranging from $7.56 to $7.60.
• Following this transaction, Mr. Nohra beneficially owns 116,610 shares of Class A Common Stock.
• The sale was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider stock sale under a 10b5-1 plan, which is generally considered neutral in sentiment as it often reflects personal financial planning rather than a change in outlook on the company's prospects.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction disclosure and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May note the director's sale, but given it's a pre-planned 10b5-1 transaction and a relatively small amount compared to total holdings, the direct impact is likely minimal.

Key Dates

Keywords

Bioventus, BVS, Insider Sale, Form 4, Director Transaction, Equity Sale, Rule 10b5-1